About Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis
Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis is a rare disease catalogued by Orphanet (ORPHA:93279). It is associated with the COL2A1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis trials.
Search ClinicalTrials.gov for "Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis" or filter by Orphanet code ORPHA:93279 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis. Updated daily.